SQZ Biotechnologies Company (SQZ) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
Tweet
Share
E-mailGet Alerts SQZ Hot Sheet
Join SI Premium – FREE
SQZ Biotechnologies Company (NYSE: SQZ) reported Q3 EPS of ($0.77), $0.05 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.47 million.
For earnings history and earnings-related data on SQZ Biotechnologies Company (SQZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Syra Health Corp. (SYRA) Reports Q3 EPS of $0.02
- Expeditors Int'l (EXPD) Tops Q3 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
